Evidence Hub

Acute Unilateral Iris Transillumination Following Topical Moxifloxacin: A Case Report and Anterior Segment Optical Coherence Tomography Findings

González Ballesteros S, Escribano Lopez P, González Guijarro JJ

Ocular immunology and inflammation, 2026

Abstract

Purpose: To describe the anterior segment swept-source optical coherence tomography (AS-SS OCT) findings of the iris in a patient with unilateral acute iris transillumination associated with iris depigmentation following topical moxifloxacin treatment for corneal trauma.

Methods: Case report.

Results: AS-SS-OCT imaging of the affected iris showed loss of the normal hyperreflective anterior iris border in both the pupillary and ciliary portions. The stromal layer appeared thinned, with patchy clusters of hyperreflective dots throughout the stroma. The homogeneous and poorly defined hyperreflectivity of the iris pigment epithelium was attenuated or completely absent in the most clinically affected areas, allowing light transmission.

Conclusions: AS-SS-OCT imaging demonstrates a distinctive pattern of iris involvement in unilateral acute iris transillumination (UAIT), which, in conjunction with clinical findings, may aid in diagnosis and reveal features overlapping with a BAIT-like phenotype, supporting its role as a valuable diagnostic tool in this entity.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free